tryptophan has been researched along with Schizophrenia in 232 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 144 (62.07) | 18.7374 |
| 1990's | 15 (6.47) | 18.2507 |
| 2000's | 20 (8.62) | 29.6817 |
| 2010's | 38 (16.38) | 24.3611 |
| 2020's | 15 (6.47) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, MI; Clarke, G; Cryan, JF; Dinan, TG; Long-Smith, C; Moloney, GM; Morkl, S; O'Mahony, SM | 1 |
| Al-Hakeim, HK; Almulla, AF; Maes, M; Solmi, M; Tunvirachaisakul, C; Vasupanrajit, A; Verkerk, R | 1 |
| Maes, M | 1 |
| Guo, L; He, H; Li, R; Liu, JC; Shi, QQ; Yu, H; Zhou, CH | 1 |
| Adhikari, BM; Buchanan, RW; Chen, S; Hare, SM; Kane-Gerard, S; Kelly, DL; Mo, C; Notarangelo, FM; Rowland, LM; Sathyasaikumar, KV; Schwarcz, R; Seneviratne, C; Wijtenburg, SA | 1 |
| Chen, J; Fang, X; Ling, Y; Liu, S; Su, KP; Tang, W; Wang, G; Wang, Y; Yang, Y; Zhang, C; Zhang, X; Zhou, C | 1 |
| Brix, S; Chen, C; Chen, Y; Dang, Y; Fan, Y; Gao, C; Guo, L; Guo, R; He, X; Jia, H; Jie, Z; Ju, Y; Kristiansen, K; Liu, B; Ma, Q; Ma, X; Madsen, L; Sun, Q; Wang, J; Wang, Q; Wang, W; Xiao, L; Xie, Y; Xu, X; Yang, H; Yang, L; Yang, Z; Zhang, T; Zhao, B; Zhu, F | 1 |
| Barbosa, DS; Geffard, M; Kanchanatawan, B; Maes, M; Michelin, AP; Moreira, EG; Semeão, LO; Sirivichayakul, S; Vojdani, A | 1 |
| Fan, N; Lu, H; Luo, Y; Ni, X; Wen, Y; Zhang, M; Zhang, Z | 1 |
| Coppens, V; De Picker, L; Kampen, JK; Morrens, M | 1 |
| Cao, B; Chen, Y; McIntyre, RS; Pan, Z; Ren, Z; Wang, D | 1 |
| Chiappelli, J; Cui, Y; Hong, LE; Huang, J; Kochunov, P; Tan, S; Tan, Y; Tian, B; Tian, L; Tong, J; Wang, Z; Yang, F; Zhang, P; Zhou, Y | 1 |
| Cathomas, F; Guetter, K; Kaiser, S; Klaus, F; Seifritz, E | 1 |
| Bartoli, F; Callovini, T; Carrà, G; Cavaleri, D; Cioni, RM; Crocamo, C | 1 |
| Miller, BJ; Wang, AK | 1 |
| Anderson, G; Carvalho, AF; Galecki, P; Kanchanatawan, B; Maes, M; Sirivichayakul, S | 1 |
| Anderson, G; Carvalho, AF; Geffard, M; Hemrungrojn, S; Kanchanatawan, B; Maes, M; Ruxrungtham, K; Sirivichayakul, S; Thika, S | 1 |
| Costa, AC; Gattaz, WF; Joaquim, HPG; Talib, LL | 1 |
| Carvalho, AF; Geffard, M; Kanchanatawan, B; Maes, M; Sirivichayakul, S; Sriswasdi, S; Stoyanov, D; Thika, S | 1 |
| Kanchanatawan, B; Maes, M | 1 |
| Guadagno, E; Li, C; Ramamurthy, J; Trakadis, Y; Wang, A; Wang, C; Zhang, E | 1 |
| Carvalho, AF; Kanchanatawan, B; Maes, M; Sirivichayakul, S; Thika, S | 1 |
| Kanchanatawan, B; Maes, M; Sriswasdi, S | 1 |
| Fujigaki, H; Mouri, A; Nabeshima, T; Saito, K; Yamamoto, Y | 1 |
| Baldessarini, RJ; Comparelli, A; Corigliano, V; Curto, M; Fazio, F; Ferracuti, S; Lionetto, L; Nicoletti, F; Simmaco, M | 1 |
| Agartz, I; Andreassen, OA; Bogdanov, M; Dieset, I; Djurovic, S; Hope, S; Jönsson, EG; Kaddurah-Daouk, R; Matson, W; Melle, I; Smeland, OB; Steen, NE; Vedal, TSJ | 1 |
| Bhat, M; Blennow, K; Cannon, TD; Engberg, G; Erhardt, S; Hultman, CM; Johansson, V; Kegel, M; Landén, M; Schwieler, L; Wetterberg, L; Zetterberg, H | 1 |
| Flegr, J | 1 |
| Aoyama, Y; Fukushima, T; Ichiba, H; Iizuka, H; Koshikawa, M; Matsumoto, Y; Nabeshima, T; Watanabe, S | 1 |
| Dippel, C; Krause, D; Müller, N; Myint, AM; Riedel, M; Schwarz, MJ; Weidinger, E | 1 |
| Banister, SD; Guillemin, GJ; Karl, T; Kassiou, M; Lim, CK; Purves-Tyson, T; Weickert, CS; Zavitsanou, K | 1 |
| Gabaeva, MV; Ganisheva, TK; Golimbet, VE; Kasparov, SV; Kolesina, NIu; Korovaĭtseva, GI; Savel'eva, TM; Snegireva, AA; Velikaia, NV | 1 |
| Abdelmoaty, S; Bhat, M; Dahl, ML; Engberg, G; Erhardt, S; Finn, A; Kegel, ME; Larsson, MK; Lundberg, K; Orhan, F; Samuelsson, M; Schuppe-Koistinen, I; Schwieler, L; Sellgren, C; Skogh, E; Svensson, C | 1 |
| De Picker, L; Dedeurwaerdere, S; Kosten, L; Staelens, S; Stroobants, S; Thomae, D; Van Eetveldt, A; Verhaeghe, J; Verkerk, R; Wyffels, L | 1 |
| Can, A; Chiappelli, J; Du, X; Fuchs, D; Hong, LE; Kochunov, P; Lowry, CA; Postolache, TT; Rowland, LM; Savransky, A; Shukla, DK; Tagamets, M; Wijtenburg, SA | 1 |
| Fukuwatari, T; Kuroki, Y; Mori, N; Sekine, A; Urata, T | 1 |
| Brenner, LA; Cook, TB; Eaton, WW; Friedl, M; Fuchs, D; Giegling, I; Groer, M; Hartmann, AM; Hoisington, AJ; Kelly, DL; Konte, B; Lowry, CA; Okusaga, O; Pandey, JP; Postolache, TT; Reeves, G; Rujescu, D; Stearns-Yoder, KA | 1 |
| Cordeiro, RC; da Silva Araújo, T; de Freitas Lima, R; de Jesus Souza Machado, M; Freitas de Lucena, D; Isabelle de Góis Queiroz, A; Macêdo, D; Maes, M; Maia Chaves Filho, AJ; Monte, AS | 1 |
| Bhat, M; Cannon, TD; Engberg, G; Erhardt, S; Hultman, CM; Johansson, V; Kegel, ME; Landén, M; Schuppe-Koistinen, I; Schwieler, L; Wetterberg, L | 1 |
| Anderson, G; Carvalho, AF; Geffard, M; Ivanova, R; Kanchanatawan, B; Maes, M; Noto, C; Ruxrungtham, K; Sirivichayakul, S; Thika, S | 1 |
| Anderson, G; Carvalho, AF; Geffard, M; Kanchanatawan, B; Maes, M; Ruxrungtham, K; Sirivichayakul, S | 1 |
| Barry, S; Clarke, G; Dinan, TG; Scully, P | 1 |
| Alexander, J; Brett, R; Henriquez, SA; Pratt, J; Roberts, CW | 1 |
| Costantino, G | 1 |
| Kim, YK; Leonard, B; Myint, AM; Scharpe, S; Steinbusch, H; Verkerk, R | 1 |
| Dougherty, GG; Kaddurah-Daouk, R; Keshavan, MS; Krishnan, RR; Matson, WR; McEvoy, J; Montrose, DM; Reddy, RD; Rozen, S; Yao, JK | 1 |
| Derakhshandeh, S; Farrashbandi, H; Saadat, I; Saadat, M | 1 |
| Bechter, K; Fuchs, D; Herzog, S; Maxeiner, HG; Reiber, H; Tumani, H | 1 |
| Dai, J; Jayathilake, K; Lee, M; Meltzer, HY | 1 |
| Dahl, ML; Engberg, G; Erhardt, S; Holtze, M; Linderholm, KR; Olsson, SK; Samuelsson, M; Skogh, E | 1 |
| Condray, R; Dougherty, GG; Haas, GL; Kaddurah-Daouk, R; Keshavan, MS; Matson, WR; McEvoy, J; Montrose, DM; Reddy, RD; Yao, JK | 1 |
| Müller, N; Myint, AM; Schwarz, MJ | 3 |
| Kim, YK; Leonard, BE; Mueller, HH; Myint, AM; Scharpé, S; Schwarz, MJ; Steinbusch, HW; Verkerk, R; Zach, J | 1 |
| Du Preez, JL; Harvey, BH; Möller, M | 1 |
| Anderson, G; Maes, M | 1 |
| Anderson, G; Berk, M; Maes, M | 1 |
| Aymard, N; Caroli, F; Clement, MN; Gauillard, J; Jacquot, M; Vacheron, MN; Viala, A | 1 |
| Kurup, AR; Kurup, PA | 1 |
| CAFRUNY, EJ; DOMINO, EF | 1 |
| AGARWAL, PS; BANERJEE, S | 1 |
| BECKETT, PG; FROHMAN, CE; GOODMAN, M; LUBY, ED; SENF, R | 1 |
| BERNSOHN, J; INSKIP, WM; LAUER, JW; ZELLER, EA | 1 |
| KOPIN, IJ | 1 |
| FLEISCHHACKER, HH; LANCASTER, JB; WHEELER, AP | 1 |
| EDELSTEIN, EL; KRASSILOWSKY, D | 1 |
| BROWN, RR; PETERS, HA; PRICE, JM | 1 |
| CARDON, PV; KETY, SS; POLLIN, W | 1 |
| BRENGELMANN, JC; PARE, CM; SANDLER, M | 1 |
| BROWN, FC; KENNEDY, JK; WHITE, JB | 1 |
| DIBNER, IM; FELDSTEIN, A; FREEMAN, H; HOAGLAND, H; HOPE, JM | 1 |
| HEATH, RG | 1 |
| GOOD, MH; YUWILER, A | 1 |
| ALEXANDER, F; CROSLEY, AP; CURTIS, GC; SPRINCE, H | 1 |
| ALEXANDER, F; JAMESON, D; PARKER, CM; SPRINCE, H | 1 |
| BENASSI, P | 1 |
| CHANG, LT; CHI, M | 1 |
| LEE, SJ | 1 |
| ALLEGRI, G; BENASSI, CA; BENASSI, P; RABASSINI, A | 1 |
| FISCHL, J; RABIAH, S | 1 |
| BERLET, HH; BULL, C; HIMWICH, HE; PSCHEIDT, GR; SPAIDE, J | 1 |
| FELIX, WR; KOPIN, IJ; LABROSSE, EH; WESTLAKE, RJ | 1 |
| BENASSI, CA; MUSAJO, L | 1 |
| Faurbye, A; Pind, K | 1 |
| BERLET, HH; BULL, C; HIMWICH, HE; KOHL, H; SPAIDE, J | 1 |
| BERNIER, JJ; PAUPE, J | 1 |
| ARONSON, H; BERTINO, J; GOODMAN, A; KLEE, GD | 1 |
| LUCAS, J; RABINOVITCH, RD; SHAW, CR | 1 |
| Bloch, Y; Fennig, S; Grauer, E; Levkovitz, Y; Ophir-Shaham, O; Treves, I | 1 |
| Brahmachari, SK; Chauhan, C; Gandhi, C; Jain, S; Saleem, Q; Verma, R | 1 |
| Sanders-Bush, E; Sodhi, MS | 1 |
| Fekkes, D; Kahn, RS; Sijben, AE; Tuinier, S; van der Heijden, FM; Verhoeven, WM | 1 |
| Crayton, JW; Hedeker, D; Hitsman, B; Pingitore, R; Spring, B; Wolf, W | 1 |
| Bell, CJ; Hood, SD; Nutt, DJ | 1 |
| Croft, RJ; Harrison, BJ; Leung, S; Nathan, PJ; O'Neill, BV; Phan, KL; Pipingas, A; Scholes, KE | 1 |
| Kim, YK; Leonard, BE; Myint, AM; Park, SH; Scharpé, S; Steinbusch, HW; Verkerk, R | 1 |
| Miüller, N; Schwarz, MJ | 1 |
| Cwik, M; Llenos, IC; Miller, CL; Walkup, J; Weis, S | 1 |
| Annable, L; Chouinard, G; Collu, R; Jones, BD | 1 |
| Sedvall, G | 1 |
| Arató, M; Banki, CM; Papp, Z | 1 |
| Anderson, GM; Cohen, DJ; Fairbanks, L; Gerner, RH; Hare, TA; Linnoila, M; Scheinin, M; Shaywitz, BA; Young, JG | 1 |
| Bender, DA | 3 |
| McDonald, A | 1 |
| Anderson, GM; Chouinard, G; Gauthier, S; Purdy, WC; Young, SN | 1 |
| Cannon-Spoor, HE; DeLisi, LE; Neckers, LM; Potkin, SG; Wyatt, RJ | 1 |
| Ervin, FR; Morand, C; Young, SN | 1 |
| Hyyppä, M; Kampman, R; Latvala, M; Rimón, R | 1 |
| Uebelhack, R | 1 |
| Belendiuk, GW; Belendiuk, K; Crayton, JW; Freedman, DX | 1 |
| Neumann, J; Sperschneider, H; Spustova, V; Stein, G | 1 |
| Benyacoub, K; Bousquet, B; Cuche, H; Deniker, P; Dreux, C; Escande, C; Loo, H; Zarifian, E | 1 |
| Breier, A | 1 |
| Hemmings, GP; Ramchand, CN; Wei, J; Xu, H | 1 |
| Bräunig, P; Gross, G; Halaris, A; Huber, G; Marler, M; Rao, ML; Strebel, B | 1 |
| Bartko, JJ; Freedman, R; Gamache, PH; Gerhardt, GA; Issa, F; Kirch, DG; Lynch, M; Suddath, RL; Wyatt, RJ | 1 |
| Bartko, JJ; Freedman, R; Gerhardt, GA; Issa, F; Kirch, DG; Suddath, RL; Wyatt, RJ | 1 |
| Askenazy, F; Candito, M; Chambon, P; Darcourt, G; Myquel, M | 1 |
| Azorin, JM; Dassa, D; Jeanningros, R; Serres, F | 1 |
| Catalano, M; Lucca, A; Lucini, V; Smeraldi, E | 1 |
| Davis, JM; Kamath, SK; Shapiro, LE; Sharma, RP; Soll, EA; Watanabe, MD | 1 |
| Aymard, N; Baldacci, C; Caroli, F; Smagghe, PO; Vacheron, MN; Viala, A | 1 |
| Arun, P; Deepadevi, KV; Kurup, PA; Manojkumar, V; Ravikumar, A | 1 |
| Gallagher, P; Golightly, KL; Hobson, JE; Lloyd, JA; Mercer, G; Young, AH | 1 |
| Degen, K; George, TP; McDougle, CJ; Potenza, MN; Sernyak, MJ; Woods, S | 1 |
| Bartlett, JR; Bridges, PK; Curzon, G; Kantamaneni, BD | 1 |
| Bousquet, B; Deniker, P; Dreux, C; Escande, C; Lôo, H; Zarifian, E | 1 |
| Bousquet, B; Dreux, C; Escande, C | 1 |
| Baker, HF; Cross, AJ; Crow, TJ; Glover, V; Joseph, MH; Killpack, WS; Lofthouse, R; Longden, A; Owen, F; Riley, GJ | 1 |
| Guchhait, RB; Janson, C; Price, WH | 1 |
| Stewart, BM | 1 |
| Smythies, JR | 1 |
| Fromen, Ch; Gottlib, D | 1 |
| Demetriou, S; Domino, EF; Klinge, V; Tuttle, T | 1 |
| Curzon, G; Kantamaneni, BD | 1 |
| Baker, HF; Crow, TJ; Jospeh, MH; Riley, GJ; Risby, D | 1 |
| Baumann, P; Gaillard, JM; Grasset, F; Laurian, S; Perey, M; Steck, A | 1 |
| Baumann, P; Gaillard, JM; Grasset, F; Laurian, S; Steck, A | 1 |
| Gaillard, JM; Tissot, R | 1 |
| Boulu, R; Poitou, P | 1 |
| Annable, L; Chouinard, Q; Sourkes, TL; Young, SN | 1 |
| Anokhina, IP; Gamaleia, NB | 1 |
| Chouinard, G; Jones, BD | 1 |
| Faktor, MI; Mukhin, AG | 1 |
| Bowers, MB; Heninger, GR | 1 |
| Boleaga, B; Castellanos, G; Eisenring, JJ; Estrada, E; Gaillard, JM; Hovaguimian, T; Hyde, A; Miranda, R; Tissot, R | 1 |
| Ax, AF; Frohman, CE; Gorham, JC; Novelly, RA | 1 |
| Taylor, WM | 1 |
| Chang, A; Neziroglu, F; Yaryura-Tobias, JA | 1 |
| Mukhin, AG | 1 |
| Dickerson, JW; Wiryanti, J | 1 |
| Barthelemy, L; Degiovanni, A; Sizaret, P | 1 |
| Tissot, R | 2 |
| Gillin, JC; Kaplan, JA; Wyatt, RJ | 1 |
| Lovett Doust, JW | 1 |
| Cowen, MA | 3 |
| Baumann, P; MGaillard, J | 1 |
| Bartlett, JR; Bridges, PK; Curzon, G; Kantamaneni, BD; Sepping, P | 1 |
| Gilka, L | 1 |
| Doust, JW; Huszka, L; Zabek, DH | 1 |
| Jakomow, B; Puzyński, S | 1 |
| Bender, DA; Gruzelier, J; Hammond, N; Pigache, RM | 1 |
| Banay-Schwartz, M; Deutsch, SI; Peace, TD; Rosse, RB; Schwartz, BL; Trinidad, AC; Zlotolow, S | 1 |
| Ancill, RJ; Goumeniouk, AD; Koczapski, AB; MacEwan, GW | 1 |
| Boni, RL; Heyes, MP; Markey, SP; Yergey, JA | 1 |
| Davis, P; Dewey, DA; DiGiambattista, S; DiJohnson, C; Kramer, MS | 1 |
| Nightingale, SL | 1 |
| Goodman, SI; Kleinman, JE; Korpi, ER; Wyatt, RJ | 2 |
| Alfredsson, G; Wiesel, FA | 1 |
| Gerner, RH; Ninan, PT; van Kammen, DP | 1 |
| Malek-Ahmadi, P | 1 |
| Cowen, PJ; Kolakowska, T; Murdock, P | 1 |
| Cowen, PJ; Gadhvi, H; Gosden, B; Kolakowska, T | 1 |
| Gorynia, I; Uebelhack, R | 1 |
| Abou-Saleh, MT; Coppen, A | 1 |
| Kitzrow, W; Uebelhack, R | 1 |
| Frohman, CE; Gottlieb, JS; Harmison, CR | 1 |
| Arthur, RE; Frohman, CE; Gottlieb, JS; Harmison, CR | 1 |
| Frohman, CE; Gottlieb, JS; Warner, KA | 1 |
| Frohman, CE; Harmison, CR | 1 |
| Arthur, RE; Frohman, CE; Gottlieb, JS; Yoon, HS | 1 |
| Laplante, M; St-Laurent, J | 1 |
| Arthur, RE; Caldwell, DF; Frohman, CE; Gottlieb, JS; Thomas, N; Zellers, R | 1 |
| Ananth, JV; Ban, TA; Lehmann, HE | 1 |
| Huszka, L; Lovett Doust, JW | 2 |
| Beckett, PG; Frohman, CE; Gottlieb, JS | 1 |
| Arthur, RE; Barry, CT; Frohman, CE; Warner, KA | 1 |
| Bueno, J; Ginther, R; Himwich, HE; Spaide, J; Tanimukai, H | 1 |
| Chiancone, FM | 1 |
| Kanig, K; Oesterle, W | 1 |
| Ottosson, JO; Rapp, W | 1 |
| Kolpakov, VG | 1 |
| Huttunen, MO | 1 |
| Gottesman, II; Nicol, S; Seal, US | 1 |
| Cerone, G; Feriozzi, F; Mancini, GM; Murri, L; Nurzia, A | 1 |
| Bamji, AN; Bender, DA | 1 |
| Filip, V; Haskovec, L; Hyánek, J; Krulík, R | 1 |
| Doust, JW | 1 |
| Bowers, MB | 2 |
| Domino, EF; Krause, RR | 2 |
| Caldwell, DF; Frohman, CE; Gottlieb, JS | 1 |
| Stancer, HC | 1 |
| Durkó, I; Huszák, I; Karsai, K | 1 |
| Gilmour, DG; Manowitz, P; Racevskis, J | 1 |
| Frosch, WA; Gilmour, DG; Manowitz, P; Shopsin, B | 1 |
| Doust, JW; Huszka, L; Little, MH | 1 |
| Caridroit, M; Duc-Aublet, F; Fontan, M; Miens, C; Testegute, T | 1 |
| Payne, IR; Walsh, EM; Whittenburg, EJ | 1 |
| Faurbye, A | 2 |
| Szafranek, J; Szafranek, K | 1 |
| Boulton, AA | 1 |
| Ban, TA | 1 |
| Bueno, JR; Ginther, R; Himwich, HE; Spaide, J; Tanimukai, H | 1 |
| Himwich, HE; Neveln, L; Spaide, J; Tolentino, J | 1 |
| Fujimori, M; Haskovec, L; Heller, B; Himwich, HE; Narasimhachari, N; Spaide, J; Tabushi, K | 1 |
| Arushanian, EB; Stoliarov, GV; Tolpyshev, BA | 1 |
| Szafranek, J | 1 |
| Bueno, JR; Himwich, HE | 1 |
| Gershon, ES; Shader, RI | 1 |
| Berlet, HH; Bull, C; Himwich, HE; Matsumoto, K; Pscheidt, GR; Spaide, J | 1 |
| Bennett, JL; Forrest, F; Hollister, LE; Moore, FF | 1 |
34 review(s) available for tryptophan and Schizophrenia
| Article | Year |
|---|---|
The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
Topics: Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenic Acid; Kynurenine; Quinolinic Acid; Schizophrenia; Tryptophan | 2022 |
Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis.
Topics: Aged; Humans; Kynurenic Acid; Kynurenine; Quinolinic Acid; Schizophrenia; Tryptophan | 2020 |
Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.
Topics: Humans; Kynurenic Acid; Kynurenine; Quinolinic Acid; Schizophrenia; Tryptophan | 2021 |
Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression.
Topics: Bipolar Disorder; Cytokines; Depressive Disorder, Major; Humans; Inflammation; Schizophrenia; Tryptophan | 2018 |
Metabolomics in patients with psychosis: A systematic review.
Topics: 3-Hydroxybutyric Acid; Aspartic Acid; Biomarkers; Bipolar Disorder; Creatine; Female; Glutamic Acid; Glutathione; Humans; Kynurenine; Lactic Acid; Linoleic Acid; Male; Metabolome; Metabolomics; Psychotic Disorders; Schizophrenia; Serine; Tryptophan | 2018 |
Linking phencyclidine intoxication to the tryptophan-kynurenine pathway: Therapeutic implications for schizophrenia.
Topics: Animals; Brain; Humans; Kynurenine; Phencyclidine; Schizophrenia; Signal Transduction; Tryptophan | 2019 |
Neuropsychiatric disease and Toxoplasma gondii infection.
Topics: Animals; Behavior; Behavior, Animal; Cats; Cytokines; Depression; Dopamine; Female; Host-Parasite Interactions; Humans; Male; Mental Disorders; Mice; Nervous System Diseases; Neurons; Neurosecretory Systems; Protozoan Proteins; Rats; Risk Factors; Schizophrenia; Serotonin; Toxoplasma; Toxoplasmosis; Toxoplasmosis, Animal; Tryptophan | 2009 |
New promises for manipulation of kynurenine pathway in cancer and neurological diseases.
Topics: Animals; Drug Delivery Systems; Drug Discovery; Humans; Huntington Disease; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Neoplasms; Schizophrenia; Tryptophan | 2009 |
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects.
Topics: Animals; Anti-Inflammatory Agents; Antipsychotic Agents; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Kynurenic Acid; Kynurenine; Mice; Molecular Targeted Therapy; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synaptic Transmission; Tryptophan | 2011 |
Immunological treatment options for schizophrenia.
Topics: Animals; Antipsychotic Agents; Astrocytes; Cyclooxygenase 2 Inhibitors; Humans; Kynurenine; Microglia; Schizophrenia; Tryptophan | 2012 |
Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
Topics: Animals; Brain; Cytokines; Disease Progression; Female; Humans; Infections; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tryptophan | 2013 |
Inflammation in schizophrenia.
Topics: Antipsychotic Agents; Brain; Humans; Inflammation; Kynurenine; Macrophages; Microglia; Monocytes; Schizophrenia; Tryptophan | 2012 |
Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways.
Topics: Animals; Comorbidity; Depressive Disorder; Humans; Inflammation; Nitrosation; Oxidative Stress; Schizophrenia; Signal Transduction; Tryptophan | 2013 |
ASPECTS OF DISORDERS OF THE KYNURENINE PATHWAY OF TRYPTOPHAN METABOLISM IN MAN.
Topics: Amino Acids; Diabetes Mellitus; Fluids and Secretions; Geriatrics; Hodgkin Disease; Humans; Kidney Calculi; Kynurenine; Leukemia; Liver Diseases; Lymphoma; Metabolic Diseases; Pregnancy; Schizophrenia; Seizures; Tryptophan; Urine; Urologic Diseases; Vitamin B 6 Deficiency; Xanthurenates | 1964 |
Serotonin and brain development.
Topics: Animals; Anxiety; Autistic Disorder; Brain; Brain Chemistry; Down Syndrome; Humans; Learning; Models, Animal; Mood Disorders; Neuronal Plasticity; Receptors, Serotonin; Schizophrenia; Serotonin; Stress, Physiological; Synapses; Tryptophan | 2004 |
Acute tryptophan depletion. Part II: clinical effects and implications.
Topics: Alleles; Alzheimer Disease; Autistic Disorder; Bipolar Disorder; Cognitive Behavioral Therapy; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Feeding and Eating Disorders; Female; Humans; Hydroxyindoleacetic Acid; Monoamine Oxidase Inhibitors; Premenstrual Syndrome; Promoter Regions, Genetic; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sleep Wake Disorders; Sleep, REM; Surveys and Questionnaires; Tryptophan | 2005 |
The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Brain; Carrier Proteins; Cyclooxygenase 2 Inhibitors; Cytokines; Dinoprostone; Dopamine; Dysbindin; Dystrophin-Associated Proteins; Glutamine; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenic Acid; Neuregulins; Psychoneuroimmunology; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Tryptophan; Tryptophan Oxygenase | 2007 |
Biochemistry of tryptophan in health and disease.
Topics: Animals; Appetite Regulation; Brain Chemistry; Depressive Disorder; Female; Hartnup Disease; Humans; Male; Malignant Carcinoid Syndrome; Pellagra; Pineal Gland; Rats; Schizophrenia; Serotonin; Sleep; Tryptophan; Tryptophan Hydroxylase; Tryptophan Oxygenase; Urinary Bladder Neoplasms | 1983 |
Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.
Topics: Amanita; Basidiomycota; Chemistry; Guatemala; Hallucinogens; History, Medieval; History, Modern 1601-; Humans; India; Mexico; Monoamine Oxidase; N,N-Dimethyltryptamine; Phenylalanine; Schizophrenia; Siberia; Tryptophan | 1980 |
Serotonin, schizophrenia and antipsychotic drug action.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Humans; Isoxazoles; Piperazines; Piperidines; Risperidone; Schizophrenia; Serotonin; Tryptophan | 1995 |
[Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
Topics: Animals; Biogenic Amines; Blood Platelets; Brain Chemistry; Catechol O-Methyltransferase; Disease Models, Animal; Dopamine; Dopamine beta-Hydroxylase; Ethylene Glycols; Growth Hormone; Hallucinogens; Homovanillic Acid; Humans; Hydroxydopamines; Monoamine Oxidase; Norepinephrine; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia; Serotonin; Tryptophan; Vanilmandelic Acid | 1979 |
The common pathophysiology of monaminergic psychoses: a new hypothesis.
Topics: 5-Hydroxytryptophan; Amino Acids; Biological Transport, Active; Bipolar Disorder; Blood-Brain Barrier; Brain; Catecholamines; Clomipramine; Dihydroxyphenylalanine; Dopamine; Electroconvulsive Therapy; Humans; Lithium; Lysergic Acid Diethylamide; Models, Biological; Monoamine Oxidase Inhibitors; Psychotic Disorders; Schizophrenia; Serotonin; Tranquilizing Agents; Tryptophan; Tyrosine | 1975 |
Disturbances in tryptophan and serotonin metabolism in affective psychoses and schizophrenia.
Topics: Affective Symptoms; Depression; Humans; Psychotic Disorders; Schizophrenia; Serotonin; Tryptophan | 1975 |
Mass spectrometric determinations of tryptophan and its metabolites.
Topics: Animals; Body Fluids; Gas Chromatography-Mass Spectrometry; Humans; Mass Spectrometry; Melatonin; Molecular Structure; Nervous System Diseases; Pineal Gland; Quinolinic Acid; Quinolinic Acids; Schizophrenia; Serotonin; Tryptophan | 1991 |
The biology of folate in depression: implications for nutritional hypotheses of the psychoses.
Topics: Anorexia Nervosa; Biogenic Amines; Brain; Depressive Disorder; Diet; Folic Acid; Folic Acid Deficiency; Homocystinuria; Humans; Models, Theoretical; Pellagra; Pterins; S-Adenosylmethionine; Schizophrenia; Tryptophan; Vitamin B 12 Deficiency | 1986 |
[Research into the biochemical bases of schizophrenic syndromes: a review].
Topics: Alpha-Globulins; Amphetamine; Ceruloplasmin; Energy Metabolism; Fenclonine; gamma-Globulins; Hallucinogens; Humans; Hydroxydopamines; Models, Theoretical; Porphyrins; Schizophrenia; Synaptic Transmission; Tryptophan; Tyrosine | 1973 |
[Biochemical treatment possibilities in psychoses].
Topics: Amino Acids; Ascorbic Acid; Dihydroxyphenylalanine; Humans; Methionine; Niacinamide; Nicotinic Acids; Phenylalanine; Psychotic Disorders; Pyridoxine; Schizophrenia; Tryptophan; Tyrosine | 1969 |
[Inadequacy of the monoamine oxidase system--the probable pathogenetic factor in schizophrenia (review)].
Topics: Adenosine Triphosphatases; Adrenochrome; Amines; Animals; Brain Chemistry; Dimethoxyphenylethylamine; Dopamine; Epinephrine; Ethanolamines; Humans; Hydroxydopamines; Metabolic Diseases; Methionine; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Oxidation-Reduction; Phenylalanine; Rats; Reserpine; Schizophrenia; Tryptamines; Tryptophan | 1974 |
[The biochemistry of mental disorders].
Topics: Bipolar Disorder; Catecholamines; Humans; Indoles; Monoamine Oxidase Inhibitors; Receptors, Neurotransmitter; Schizophrenia; Tryptophan | 1970 |
Psychopharmacology. Yesterday, today and tomorrow: a point of view.
Topics: Affective Symptoms; Amitriptyline; Antidepressive Agents; Canada; Carbonates; Depression; Dihydroxyphenylalanine; Drug Industry; Electroconvulsive Therapy; Humans; Imipramine; Lithium; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Nicotinic Acids; Psychopharmacology; Research Support as Topic; Schizophrenia; Tranquilizing Agents; Tryptophan; Vitamins | 1973 |
The role of amines in the etiology of schizophrenia.
Topics: Adrenochrome; Amines; Amphetamine; Brain Chemistry; Dopamine; Epinephrine; Humans; Indoles; Kynurenine; Mescaline; Monoamine Oxidase Inhibitors; Norepinephrine; Phenethylamines; Phenylalanine; Psychoses, Substance-Induced; Schizophrenia; Serotonin; Tryptamines; Tryptophan | 1968 |
[Tryptophan and its metabolism in schizophrenia].
Topics: Chlorpromazine; Drug Synergism; Haloperidol; Humans; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Nicotinic Acids; Schizophrenia; Serotonin; Tryptophan; Xanthurenates | 1970 |
Biochemical research in schizophrenia.
Topics: Brain; Chromatography, Paper; Hallucinogens; Humans; Methionine; Methylation; Motor Activity; Phenethylamines; Phenylalanine; Schizophrenia; Tryptamines; Tryptophan | 1971 |
Drug treatment in schizophrenia.
Topics: Butyrophenones; Chlorpromazine; Evaluation Studies as Topic; Humans; Phenothiazines; Phenylalanine; Reserpine; Schizophrenia; Thiothixene; Tranquilizing Agents; Tryptophan; Xanthenes | 1971 |
22 trial(s) available for tryptophan and Schizophrenia
| Article | Year |
|---|---|
Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow.
Topics: Animals; Cerebrovascular Circulation; Cognition; Cross-Over Studies; Humans; Kynurenic Acid; Kynurenine; Rats; Rats, Wistar; Schizophrenia; Tryptophan | 2023 |
Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Cytokines; Female; Humans; Kynurenine; Male; Schizophrenia; Time Factors; Tryptophan | 2009 |
3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chromatography, High Pressure Liquid; Diagnostic and Statistical Manual of Mental Disorders; Humans; Kynurenine; Monte Carlo Method; Neuropsychological Tests; Psychotic Disorders; Schizophrenia; Tryptophan; Young Adult | 2011 |
Effect of L-tryptophan on memory in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memory; Memory Disorders; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Tryptophan | 2003 |
Acute serotonin and dopamine depletion improves attentional control: findings from the stroop task.
Topics: Adult; Attention; Biogenic Monoamines; Brain; Brain Chemistry; Dopamine; Double-Blind Method; Humans; Male; Mood Disorders; Neural Pathways; Neuropsychological Tests; Placebos; Schizophrenia; Serotonin; Synaptic Transmission; Tryptophan; Tyrosine | 2007 |
Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Topics: Adult; Aged; Antipsychotic Agents; Benserazide; Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Time Factors; Tryptophan | 1981 |
A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses.
Topics: Adult; Biogenic Amines; Chromatography, High Pressure Liquid; Chronic Disease; Dopamine; Double-Blind Method; Female; Haloperidol; Humans; Kynurenine; Male; Norepinephrine; Schizophrenia; Schizophrenic Psychology; Serotonin; Tryptophan; Tyrosine | 1994 |
A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: II. Correlations with psychopathology.
Topics: Adult; Biogenic Amines; Dopamine; Double-Blind Method; Female; Haloperidol; Humans; Kynurenine; Male; Norepinephrine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Serotonin; Tryptophan; Tyrosine | 1994 |
Neutral amino acid availability in two major psychiatric disorders.
Topics: Adolescent; Adult; Aged; Amino Acids; Depressive Disorder; Diet; Female; Humans; Male; Middle Aged; Schizophrenia; Tryptophan | 1995 |
Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms.
Topics: Adult; Brain; Cross-Over Studies; Delusions; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Serotonin; Tryptophan | 1997 |
Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Depressive Disorder; Drug Monitoring; Female; Fluoxetine; Humans; Male; Middle Aged; Schizophrenia; Serotonin; Tryptophan | 1999 |
Acute tryptophan depletion in schizophrenia.
Topics: Administration, Oral; Adult; Affect; Amino Acids; Blood-Brain Barrier; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Protein Biosynthesis; Schizophrenia; Severity of Illness Index; Treatment Outcome; Tryptophan | 2001 |
Acute tryptophan depletion in schizophrenic patients treated with clozapine.
Topics: Adult; Brain; Clozapine; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Serotonin; Tryptophan | 2002 |
A controlled study of tryptophan-benserazide in schizophrenia.
Topics: Adult; Aged; Benserazide; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrazines; Kynurenine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Tryptophan | 1978 |
Evidence of brain dopamine deficiency in schizophrenia.
Topics: Benserazide; Brain; Chlorpromazine; Dopamine; Double-Blind Method; Drug Therapy, Combination; Humans; Methyldopa; Receptors, Dopamine; Rubidium; Schizophrenia; Serotonin; Tryptophan | 1979 |
Clinical effects of tryptophan in chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Humans; Male; Placebos; Pyridoxine; Schizophrenia; Tryptophan | 1976 |
Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophrenia.
Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antipsychotic Agents; Behavior; Combined Modality Therapy; Humans; Irritable Mood; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Time Factors; Tryptophan | 1992 |
Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment.
Topics: Adolescent; Adult; Amino Acids; Biogenic Monoamines; Female; Glutamates; Glutamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Meglutol; Schizophrenia; Sulpiride; Tryptophan; Tyrosine | 1989 |
Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics.
Topics: Adult; Aminobutyrates; Antipsychotic Agents; Canada; Clinical Trials as Topic; Drug Synergism; Female; Hospitals, Psychiatric; Humans; Length of Stay; Male; Methionine; Middle Aged; Nicotinic Acids; Phenothiazines; Placebos; Psychiatric Status Rating Scales; Pyridoxine; Schizophrenia; Tryptophan | 1973 |
Influence of some psychoactive drugs on mineral metabolism in man.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Adult; Analysis of Variance; Antipsychotic Agents; Benztropine; Body Weight; Butyrophenones; Calcium; Female; Glycine; Humans; Magnesium; Middle Aged; Phenelzine; Phenothiazines; Placebos; Potassium; Psychiatric Status Rating Scales; Schizophrenia; Sodium; Tryptophan | 1973 |
Free and bound serum tryptophan in drug-free normal controls and chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Drug Tolerance; Fasting; Fluorometry; Humans; Male; Middle Aged; Protein Binding; Schizophrenia; Time Factors; Tryptophan | 1974 |
Metabolic control of body temperature in man.
Topics: Adult; Body Temperature Regulation; Circadian Rhythm; Female; Humans; Middle Aged; Norepinephrine; Phenelzine; Placebos; Schizophrenia; Serotonin; Time Factors; Tryptophan | 1973 |
176 other study(ies) available for tryptophan and Schizophrenia
| Article | Year |
|---|---|
The immune-kynurenine pathway in social anxiety disorder.
Topics: Female; Humans; Kynurenic Acid; Kynurenine; Male; Phobia, Social; Schizophrenia; Tryptophan | 2022 |
Major neurocognitive psychosis: a novel schizophrenia endophenotype class that is based on machine learning and resembles Kraepelin's and Bleuler's conceptions.
Topics: Endophenotypes; Humans; Machine Learning; Psychotic Disorders; Schizophrenia; Tryptophan | 2023 |
A Preliminary Comparison of Plasma Tryptophan Metabolites and Medium- and Long-Chain Fatty Acids in Adult Patients with Major Depressive Disorder and Schizophrenia.
Topics: Adult; Depressive Disorder, Major; Fatty Acids; Fatty Acids, Omega-3; Humans; Reproducibility of Results; Schizophrenia; Tryptophan | 2023 |
The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
Topics: Electroconvulsive Therapy; Humans; Interleukin-18; Kynurenic Acid; Kynurenine; RNA, Messenger; Schizophrenia; Treatment Outcome; Tryptophan | 2023 |
Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice.
Topics: Animals; Case-Control Studies; Dopamine; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Kynurenic Acid; Kynurenine; Male; Mice; Schizophrenia; Schizophrenic Psychology; Serotonin; Tryptophan | 2020 |
Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways.
Topics: Adult; Biomarkers; Female; Humans; Immunoglobulin A; Immunoglobulin M; Male; Neurotoxins; Schizophrenia; Severity of Illness Index; Tryptophan | 2019 |
Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
Topics: Adult; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Ketamine; Kynurenic Acid; Kynurenine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Substance-Related Disorders; Tandem Mass Spectrometry; Time Factors; Tryptophan; Young Adult | 2020 |
Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia.
Topics: Humans; Kynurenic Acid; Kynurenine; Memory, Short-Term; Quinolinic Acid; Schizophrenia; Tryptophan | 2021 |
Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder.
Topics: Adult; Case-Control Studies; Cognition; Cognitive Dysfunction; Depressive Disorder, Major; Female; Humans; Kynurenine; Male; Middle Aged; Quinolinic Acid; Schizophrenia; Tryptophan; Young Adult | 2021 |
The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites.
Topics: Bipolar Disorder; Humans; Kynurenic Acid; Kynurenine; Schizophrenia; Tryptophan | 2021 |
Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Case-Control Studies; Cyclothymic Disorder; Depression; Female; Humans; Immunoglobulin A; Immunoglobulin M; Male; Middle Aged; Schizophrenia; Signal Transduction; Tryptophan; Young Adult | 2018 |
Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
Topics: Adult; Case-Control Studies; Female; Humans; Linear Models; Male; Memory Disorders; Memory, Episodic; Multivariate Analysis; Neuropsychological Tests; Schizophrenia; Semantics; Tryptophan | 2018 |
Kynurenine is correlated with IL-1β in plasma of schizophrenia patients.
Topics: Adult; Female; Humans; Interleukin-1beta; Kynurenine; Male; Schizophrenia; Tryptophan | 2018 |
Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis.
Topics: Adult; Behavioral Symptoms; Cognitive Reserve; Cytokines; Female; Humans; Inflammation; Male; Middle Aged; Neurocognitive Disorders; Neuroimmunomodulation; Patient Acuity; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Tryptophan; Unsupervised Machine Learning | 2018 |
The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Cognition Disorders; Executive Function; Female; Humans; Immunoglobulin A; Immunoglobulin M; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Male; Middle Aged; Neuropsychological Tests; Picolinic Acids; Psychiatric Status Rating Scales; Quinolinic Acid; Schizophrenia; Schizophrenic Psychology; Tryptophan; Xanthurenates; Young Adult | 2018 |
A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
Topics: Anxiety; Anxiety Disorders; Humans; Memory Disorders; Neuropsychological Tests; Schizophrenia; Tryptophan; Xanthurenates | 2019 |
Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
Topics: Adolescent; Adult; Aged; Anxiety; Biomarkers; Case-Control Studies; Depression; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Quality of Life; Schizophrenia; Schizophrenic Psychology; Supervised Machine Learning; Tryptophan; Young Adult | 2019 |
Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.
Topics: Adolescent; Adult; Disease Progression; Female; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; Male; ortho-Aminobenzoates; Prodromal Symptoms; Psychotic Disorders; Quinolinic Acid; Risk; Schizophrenia; Tryptophan; Xanthurenates; Young Adult | 2019 |
Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.
Topics: Adolescent; Adult; Bipolar Disorder; Female; Humans; Kynurenine; Male; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Psychotic Disorders; Schizophrenia; Tryptophan; Tyrosine; Young Adult | 2020 |
Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid.
Topics: Adult; Aged; Bipolar Disorder; Chemokine CCL2; Cohort Studies; Female; Humans; Kynurenic Acid; Male; Middle Aged; Quinolinic Acid; Schizophrenia; Sweden; Tryptophan | 2020 |
How and why Toxoplasma makes us crazy.
Topics: Accidents, Occupational; Accidents, Traffic; Animals; Behavior; Brain; Cats; Dopamine; Female; Humans; Male; Mice; Pregnancy; Risk Factors; Schizophrenia; Sexually Transmitted Diseases; Suicide; Testosterone; Toxoplasma; Toxoplasmosis; Tryptophan | 2013 |
Decreased L-tryptophan concentration in distinctive brain regions of mice treated repeatedly with phencyclidine.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Excitatory Amino Acid Antagonists; Isothiocyanates; Male; Mice; Oxadiazoles; Phencyclidine; Schizophrenia; Tryptophan | 2013 |
Impact of different antipsychotics on cytokines and tryptophan metabolites in stimulated cultures from patients with schizophrenia.
Topics: Antipsychotic Agents; Cell Culture Techniques; Cytokines; Female; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Tryptophan | 2013 |
Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibition.
Topics: Animals; Brain; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dizocilpine Maleate; Female; Gestational Age; Hyperkinesis; Kynurenic Acid; Kynurenine; Male; Picolinic Acids; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Pyrazoles; Quinolinic Acid; Random Allocation; Rats; Rats, Wistar; Schizophrenia; Sexual Maturation; Sulfonamides; Tryptophan | 2014 |
[A study of IL-1Β and IDO gene polymorphisms in patients with schizophrenia].
Topics: Adult; Alleles; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interleukin-1beta; Kynurenine; Male; Metabolic Networks and Pathways; Minisatellite Repeats; Polymorphism, Genetic; Schizophrenia; Tryptophan; Young Adult | 2014 |
Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.
Topics: Adult; Astrocytes; Cells, Cultured; Cerebral Cortex; Chronic Disease; Female; Humans; Interleukin-6; Interleukin-8; Kynurenic Acid; Kynurenine; Male; Middle Aged; Schizophrenia; Tryptophan; Young Adult | 2015 |
Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
Topics: Animals; Brain; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Kynurenine; Male; Molecular Imaging; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tryptophan | 2016 |
Tryptophan Metabolism and White Matter Integrity in Schizophrenia.
Topics: Adult; Analysis of Variance; Anisotropy; Diffusion Tensor Imaging; Female; Glutamic Acid; Humans; Kynurenine; Magnetic Resonance Spectroscopy; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Tryptophan; White Matter; Young Adult | 2016 |
Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amino Acid Transport Systems, Neutral; Animals; Brain; Kynurenic Acid; Kynurenine; Male; Rats, Wistar; Schizophrenia; Tryptophan | 2016 |
Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.
Topics: Adult; Female; Gliadin; Humans; Immunoglobulin G; Kynurenine; Male; Middle Aged; Schizophrenia; Tryptophan | 2016 |
Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.
Topics: Animals; Antipsychotic Agents; Brain; Disease Models, Animal; Immunologic Factors; Immunomodulation; Interleukin-4; Interleukin-6; Ketamine; Male; Melatonin; Mice; Neuroimmunomodulation; Random Allocation; Risperidone; Schizophrenia; Schizophrenic Psychology; Tryptophan | 2017 |
Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
Topics: Bipolar Disorder; Female; Humans; Interleukin-6; Interleukin-8; Kynurenic Acid; Male; Middle Aged; Personality; Psychotic Disorders; Quinolinic Acid; Schizophrenia; Schizophrenic Psychology; Tryptophan; Tumor Necrosis Factor-alpha; Twins | 2017 |
Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.
Topics: Adolescent; Adult; Aged; Anxiety; Cognition Disorders; Depression; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Symptom Assessment; Tryptophan; Young Adult | 2017 |
Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
Topics: Adult; Biomarkers; Female; Humans; Immunity, Cellular; Immunoglobulin M; Kynurenic Acid; Male; Metabolism; Middle Aged; Quinolinic Acid; Schizophrenia; Schizophrenic Psychology; Signal Transduction; Tryptophan; Xanthurenates | 2018 |
Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
Topics: Adult; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Kynurenine; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Tryptophan; Up-Regulation | 2009 |
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Hydroxyindoleacetic Acid; Kynurenine; Male; Melatonin; Oxidative Stress; Schizophrenia; Serotonin; Tryptophan; Young Adult | 2010 |
Association between genetic polymorphism of XRCC1 Arg194Trp and risk of schizophrenia.
Topics: Arginine; Case-Control Studies; Chi-Square Distribution; DNA-Binding Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Risk Factors; Schizophrenia; Tryptophan; X-ray Repair Cross Complementing Protein 1 | 2009 |
Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction.
Topics: Adult; Cohort Studies; Female; Humans; Immunoglobulins; International Classification of Diseases; Kynurenine; Male; Middle Aged; Mood Disorders; Neopterin; Psychiatric Status Rating Scales; Schizophrenia; Statistics, Nonparametric; Tomography, X-Ray Computed; Tryptophan | 2010 |
Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration.
Topics: Adult; Amino Acids, Neutral; Analysis of Variance; Antipsychotic Agents; Female; Humans; Hydrocortisone; Male; Psychiatric Status Rating Scales; Radioimmunoassay; Schizophrenia; Statistics as Topic; Tryptophan; Young Adult | 2011 |
Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; Olanzapine; Schizophrenia; Tryptophan; Up-Regulation; Young Adult | 2012 |
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
Topics: Adult; Algorithms; Antipsychotic Agents; Chromatography, High Pressure Liquid; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; Patient Discharge; Schizophrenia; Schizophrenic Psychology; Spectrophotometry, Ultraviolet; Treatment Outcome; Tryptophan | 2011 |
Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
Topics: 3-Hydroxyanthranilic Acid; Animals; Charcoal; Chromatography, High Pressure Liquid; Depression; Kynurenic Acid; Kynurenine; Linear Models; Male; ortho-Aminobenzoates; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Schizophrenia; Social Isolation; Solid Phase Extraction; Tandem Mass Spectrometry; Tryptophan | 2012 |
Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanilli
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Female; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Risperidone; Schizophrenia; Serotonin; Tryptophan | 2002 |
Membrane Na(+)-K+ ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia--relationship to hemispheric dominance.
Topics: Adult; Bipolar Disorder; Depressive Disorder, Major; Digoxin; Dominance, Cerebral; Humans; Hydroxymethylglutaryl CoA Reductases; Magnesium; Sampling Studies; Schizophrenia; Sodium-Potassium-Exchanging ATPase; Tryptophan; Tyrosine | 2002 |
Urinary excretion of some products of tryptophan metabolism in schizophrenic patients.
Topics: Humans; Schizophrenia; Tryptophan | 1958 |
Tryptophan-nicotinic acid metabolism in schizophrenia.
Topics: Biochemical Phenomena; Niacin; Schizophrenia; Tryptophan | 1958 |
Ceruloplasmin, transferrin, and tryptophan in schizophrenia.
Topics: Ceruloplasmin; Globulins; Humans; Iron; Oxidation-Reduction; Schizophrenia; Serum Globulins; Transferrin; Tryptophan | 1958 |
Observations of schizophrenic patients after iproniazid and tryptophan.
Topics: Iproniazid; Isomerism; Niacin; Nicotinic Acids; Schizophrenia; Tryptophan | 1958 |
Tryptophan loading and excretion of 5-hydroxyindoleacetic acid in normal and schizophrenic subjects.
Topics: Biological Transport; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Schizophrenia; Tryptophan | 1959 |
Studies in schizophrenia, V. Disturbances of protein and tryptophan metabolism and toxicity of urine.
Topics: Humans; Proteins; Schizophrenia; Tryptophan; Urine | 1959 |
Investigations on the tryptophan content of urines from schizophrenics and other psychotic patients.
Topics: Humans; Mental Disorders; Psychotic Disorders; Schizophrenia; Tryptophan | 1959 |
Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseases.
Topics: Humans; Mental Disorders; Porphyrias; Schizophrenia; Tryptophan | 1959 |
Effects of amino acid feedings in schizophrenic patients treated with iproniazid.
Topics: Amino Acids; Diet; Humans; Iproniazid; Methionine; Nutrition Assessment; Schizophrenia; Tryptophan | 1961 |
Effects of 5-hydroxytryptophan on schizophrenia.
Topics: 5-Hydroxytryptophan; Brain; Humans; Neurochemistry; Schizophrenia; Serotonin; Tryptophan | 1959 |
Urinary excretion of tryptophan metabolites by schizophrenic individuals.
Topics: Humans; Schizophrenia; Tryptophan | 1960 |
The administration of BAS, 5-HTP, and marsilid to schizophrenic patients.
Topics: 5-Hydroxytryptophan; Humans; Isoniazid; Schizophrenia; Serotonin; Tryptophan | 1959 |
Reappraisal of biological aspects of psychiatry.
Topics: Biochemical Phenomena; Blood; Blood Chemical Analysis; Humans; Psychiatry; Schizophrenia; Tryptophan | 1961 |
Chromatographic study of "Reigelhaupt" chromogens in urine.
Topics: Chromatography; Humans; Indican; Indoles; Naphthalenesulfonates; Schizophrenia; Tryptophan | 1962 |
L-METHIONINE AND L-TRYPTOPHAN FEEDINGS IN NON-PSYCHOTIC AND SCHIZOPHRENIC PATIENTS WITH AND WITHOUT TRANYLCYPROMINE.
Topics: Ammonia; Chlorides; Humans; Jews; Methionine; Neurotic Disorders; Potassium; Schizophrenia; Sodium; Toxicology; Tranylcypromine; Tryptophan; Urine | 1963 |
URINARY INDOLES IN SCHIZOPHRENIC AND PSYCHONEUROTIC PATIENTS AFTER ADMINISTRATION OF TRANYLCYPROMINE (PARNATE) AND METHIONINE OR TRYPTOPHAN.
Topics: Chromatography; Creatine; Creatinine; Humans; Indoles; Methionine; Neurotic Disorders; Placebos; Schizophrenia; Tranylcypromine; Tryptophan; Urine | 1963 |
[CONTRIBUTION TO THE KNOWLEDGE OF THE NEUROCHEMICAL ASPECTS OF SCHIZOPHRENIA].
Topics: Biochemical Phenomena; Biochemistry; Humans; Metabolism; Nervous System; Schizophrenia; Tryptophan | 1963 |
AN INVESTIGATION INTO THE PROTEIN METABOLISM OF SCHIZOPHRENICS AND ITS CLINICAL SIGNIFICANCE.
Topics: China; Chromatography; Cysteine; Cystine; Indoles; Kidney; Proteins; Renal Aminoacidurias; Schizophrenia; Tryptophan | 1963 |
[STUDIES ON URINARY EXCRETION OF 5-HYDROXYINDOLEACETIC ACID].
Topics: Asian People; Child; China; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Korea; Metabolism; Peptic Ulcer; Republic of Korea; Schizophrenia; Serotonin; Tranquilizing Agents; Tryptophan; Urine | 1963 |
TRYPTOPHAN METABOLISM IN SPECIAL PAIRS OF TWINS.
Topics: Chromatography; Diseases in Twins; Genetics, Medical; Kynurenic Acid; Kynurenine; Metabolic Diseases; ortho-Aminobenzoates; Proteins; Schizophrenia; Spectrophotometry; Tryptophan; Urine; Xanthurenates | 1964 |
DETERMINATION OF FREE AND TOTAL INDOLE-3-ACETIC ACID AND OF THE INDOLE INDEX.
Topics: Friedreich Ataxia; Humans; Indoleacetic Acids; Indoles; Intestines; Kynurenine; Metabolism; Myotonia; Phenylketonurias; Poisoning; Research; Schizophrenia; Tryptophan; Urine | 1964 |
EXCRETION OF CATECHOLAMINES AND EXACERBATION OF SYMPTOMS IN SCHIZOPHRENIC PATIENTS.
Topics: Catecholamines; Dopamine; Epinephrine; Fluids and Secretions; Mandelic Acids; Metabolism; Methionine; Norepinephrine; Schizophrenia; Tryptophan; Urine | 1964 |
URINARY TRYPTAMINE AND INDOLE-3-ACETIC ACID EXCRETION BY SCHIZOPHRENIC PATIENTS: USE OF THE TRYPTAMINE/INDOLE ACETIC ACID RATIO AS AN INDEX OF MONOAMINE OXIDASE INHIBITION.
Topics: Amino Acids; Fluids and Secretions; Glutamine; Glycine; Histidine; Humans; Indoleacetic Acids; Indoles; Iproniazid; Metabolism; Methionine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pharmacology; Phenylalanine; Schizophrenia; Tryptamines; Tryptophan; Urine | 1964 |
INVESTIGATIONS ON THE TRYPTOPHANE METABOLISM (VIA KYNURENINE) IN SCHIZOPHRENIC PATIENTS.
Topics: Amino Acids; Humans; Kynurenine; Schizophrenia; Tryptophan; Urine; Xanthurenates | 1964 |
EFFECTS OF REDUCTION OF TRYPTOPHAN AND METHIONINE INTAKE ON URINARY INDOLE COMPOUNDS AND SCHIZOPHRENIC BEHAVIOR.
Topics: Behavior; Biochemical Phenomena; Biochemistry; Dietary Proteins; Humans; Indoles; Methionine; Proteins; Schizophrenia; Tryptophan; Urine | 1965 |
[AN ENDOGENOUS METABOLIC FACTOR IN SCHIZOPHRENIC BEHAVIOR].
Topics: Amino Acids; Humans; Methionine; Research; Schizophrenia; Tryptophan | 1965 |
The effects of 5-hydroxytryptophan (a serotonin precursor) in schizophrenic patients.
Topics: 5-Hydroxytryptophan; Schizophrenia; Serotonin; Tryptophan | 1960 |
Metabolic studies in childhood schizophrenia. Effect of tryptophan loading on indole excretion.
Topics: Child; Indoleacetic Acids; Indoles; Infant; Schizophrenia; Schizophrenia, Childhood; Tryptophan | 1959 |
A nonsense mutation in the synaptogyrin 1 gene in a family with schizophrenia.
Topics: Blotting, Northern; Brain; Codon, Nonsense; DNA Mutational Analysis; Exons; Family Health; Female; Humans; Male; Molecular Biology; Nerve Tissue Proteins; Pedigree; Phosphoric Monoester Hydrolases; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schizophrenia; Threonine; Tryptophan | 2004 |
Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics?
Topics: Adult; Amino Acids, Neutral; Antipsychotic Agents; Brain; Down-Regulation; Drug Resistance; Female; Humans; Male; Middle Aged; Schizophrenia; Serotonin; Tryptophan | 2005 |
Effects of acute tryptophan depletion on negative symptoms and smoking topography in nicotine-dependent schizophrenics and nonpsychiatric controls.
Topics: Adult; Female; Humans; Male; Middle Aged; Psychotic Disorders; Reference Values; Schizophrenia; Smoking; Tobacco Use Disorder; Tryptophan | 2005 |
Tryptophan breakdown pathway in bipolar mania.
Topics: Adult; Aspartic Acid; Bipolar Disorder; Brief Psychiatric Rating Scale; Female; Gyrus Cinguli; Humans; Kynurenic Acid; Kynurenine; Male; Schizophrenia; Severity of Illness Index; Tryptophan | 2007 |
Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
Topics: 3-Hydroxyanthranilic Acid; Adult; Biomarkers; Bipolar Disorder; Brain; Chromatography, High Pressure Liquid; Female; Gyrus Cinguli; Humans; Kynurenine; Middle Aged; Niacinamide; Predictive Value of Tests; Schizophrenia; Signal Transduction; Suicide; Tryptophan; Tryptophan Oxygenase | 2008 |
Serotonin metabolite concentrations in cerebrospinal fluid from schizophrenic patients -- relationships to family history.
Topics: Female; Humans; Hydroxyindoleacetic Acid; Male; Reference Values; Schizophrenia; Serotonin; Sex Factors; Tryptophan | 1981 |
Cerebrospinal fluid biochemical examinations: do they reflect clinical or biological differences?
Topics: Adult; Aged; Alcoholism; Bipolar Disorder; Calcium; Depressive Disorder; Dexamethasone; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Middle Aged; Schizophrenia; Tryptophan | 1983 |
CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
Topics: Adolescent; Adult; Age Factors; Aged; Bipolar Disorder; Calcium; Choline; Depressive Disorder; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Research Design; Schizophrenia; Tryptophan; Tyrosine | 1984 |
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
Topics: 5-Hydroxytryptophan; Adult; Benserazide; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Humans; Hydrazines; Middle Aged; Parkinson Disease; Schizophrenia; Tryptophan | 1982 |
Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia.
Topics: Administration, Oral; Adult; Heterozygote; Humans; Infusions, Parenteral; Phenylalanine; Phenylketonurias; Schizophrenia; Tryptophan; Tyrosine | 1983 |
Clinical response of aggressive schizophrenics to oral tryptophan.
Topics: Administration, Oral; Adult; Aggression; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Tryptophan | 1983 |
Cerebrospinal fluid tryptophan and brain atrophy in patients with chronic schizophrenia.
Topics: Adult; Atrophy; Brain; Female; Humans; Male; Middle Aged; Schizophrenia; Sex Factors; Tryptophan | 1982 |
[Studies of the indolamine metabolism in endogenous psychoses].
Topics: Blood Platelets; Brain; Depressive Disorder; Humans; Methyltransferases; Monoamine Oxidase; Psychotic Disorders; Schizophrenia; Serotonin; Tryptophan | 1982 |
Blood tryptophan metabolism in chronic schizophrenics.
Topics: Adult; Blood Platelets; Chronic Disease; Humans; Male; Monoamine Oxidase; Oxidoreductases Acting on CH-NH Group Donors; Schizophrenia; Schizophrenia, Paranoid; Serotonin; Tryptophan | 1981 |
Middle molecular weight substances and tryptophan in cerebrospinal fluid of schizophrenic patients.
Topics: Adolescent; Adult; Aged; Chromatography, Gel; Female; Humans; Male; Middle Aged; Schizophrenia; Toxins, Biological; Tryptophan | 1981 |
Measurement of the plasmatic level of free and protein-bound tryptophan in mental pathology.
Topics: Bipolar Disorder; Humans; Reference Values; Schizophrenia; Schizophrenic Psychology; Serotonin; Tryptophan | 1980 |
Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset.
Topics: Adult; Age of Onset; Brain; Chromatography, High Pressure Liquid; Homovanillic Acid; Humans; Male; Middle Aged; Phenylalanine; Schizophrenia; Tryptophan; Tyrosine | 1995 |
Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Circadian Rhythm; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Melatonin; Middle Aged; Neural Inhibition; Pituitary Hormones; Prolactin; Reference Values; Schizophrenia; Schizophrenic Psychology; Serotonin; Thyrotropin; Tryptophan | 1994 |
Tryptophanemia and tyrosinemia in adolescents with impulsive behavior.
Topics: Adolescent; Aggression; Amino Acids; Anorexia Nervosa; Borderline Personality Disorder; Female; Humans; Impulsive Behavior; Male; Schizophrenia; Schizophrenic Psychology; Serotonin; Social Behavior Disorders; Tryptophan; Tyrosine | 1993 |
Decrease in red blood cell L-tryptophan uptake in schizophrenic patients: possible link with loss of impulse control.
Topics: Adult; Aged; Erythrocytes; Female; Humans; Kinetics; Male; Middle Aged; Radioligand Assay; Schizophrenia; Tryptophan | 1995 |
Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders.
Topics: Adult; Biogenic Monoamines; Brain Diseases; Brain Neoplasms; Digoxin; Epilepsy, Generalized; Erythrocytes; Fatty Acids, Nonesterified; Female; Glioma; Glycine Agents; Humans; Hydroxymethylglutaryl CoA Reductases; Kynurenic Acid; Magnesium; Male; Microvascular Angina; Middle Aged; Morphine; Narcotics; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinolinic Acid; Schizophrenia; Serum Albumin; Sodium-Potassium-Exchanging ATPase; Strychnine; Tryptophan; Tyrosine; Ubiquinone | 2000 |
Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.
Topics: Cerebral Ventricles; Frontal Lobe; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Neurotic Disorders; Neurotransmitter Agents; Phenylacetates; Schizophrenia; Tryptophan; Tyrosine | 1976 |
[Study of free and total tryptophan in the plasma. It value in psychiatry].
Topics: Adult; Chlorpromazine; Female; Humans; Lithium; Male; Middle Aged; Phenothiazines; Schizophrenia; Spectrometry, Fluorescence; Tryptophan | 1976 |
[Fluorometric determination of free and total tryptophan in blood plasma].
Topics: Depression; Fluorometry; Heparin; Humans; Hydrogen-Ion Concentration; Protein Binding; Schizophrenia; Temperature; Tryptophan; Ultracentrifugation; Ultrafiltration | 1977 |
Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings.
Topics: Aged; Brain Chemistry; Catechol O-Methyltransferase; Chronic Disease; Dopamine; Dopamine beta-Hydroxylase; Female; Humans; Hydroxyindoleacetic Acid; Kynurenine; Male; Monoamine Oxidase; Norepinephrine; Phenylacetates; Schizophrenia; Serotonin; Tryptophan; Tyrosine 3-Monooxygenase | 1979 |
Validity of plasma factor in schizophrenia as measured by tryptophan uptake.
Topics: Aged; Alpha-Globulins; Animals; Calcium; Chickens; Complement System Proteins; Edetic Acid; Erythrocytes; Guinea Pigs; Hemolysis; Humans; Male; Mental Disorders; Middle Aged; Plasma; Schizophrenia; Temperature; Tryptophan | 1975 |
Letter: Serum-aminoacids and brain tryptophan uptake.
Topics: Amino Acids; Animals; Brain; Chlorpromazine; Humans; Rats; Schizophrenia; Serotonin; Tryptophan | 1975 |
Biochemical aspects of schizophrenia.
Topics: Adenosine Triphosphate; Alpha-Globulins; Autoantibodies; Citric Acid Cycle; Humans; Immunoglobulin G; Schizophrenia; Serotonin; Tryptophan | 1975 |
Recent progress in schizophrenia research.
Topics: Adolescent; Animals; Brain; Diet; Dopamine; Female; Humans; Methylation; Rats; Schizophrenia; Serotonin; Tryptophan; Tyrosine | 1976 |
[Attempt to isolate an active enzyme fraction for use in the treatment of schizophrenia].
Topics: Alpha-Globulins; Brain; Humans; Molecular Conformation; Schizophrenia; Tryptophan | 1975 |
Tryptophan and serotonin in schizophrenia.
Topics: Brain; Humans; Receptors, Serotonin; Schizophrenia; Serotonin; Tryptophan | 1976 |
Comparison of the visually evoked response in drug-free chronic schizophrenic patients and normal controls.
Topics: Adult; Electroencephalography; Evoked Potentials; Humans; Male; Occipital Lobe; Photic Stimulation; Reaction Time; Schizophrenia; Schizophrenic Psychology; Tryptophan; Visual Perception | 1979 |
Transmitters and related substances in brain material: an index of terminal and/or post-mortem biochemical change.
Topics: Brain; Carboxy-Lyases; Cauda Equina; Glutamate Decarboxylase; Humans; Huntington Disease; Neurotransmitter Agents; Nucleus Accumbens; Postmortem Changes; Schizophrenia; Tryptophan | 1978 |
Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjects.
Topics: Aged; Aging; Brain; Female; Humans; Hydroxyindoleacetic Acid; Kynurenine; Male; Middle Aged; Myocardial Infarction; Postmortem Changes; Schizophrenia; Serotonin; Sex Factors; Tryptophan | 1979 |
Distribution of tryptophan in erythrocytes, leukocytes and thrombocytes, and its binding to plasma albumin.
Topics: Biological Transport, Active; Blood Platelets; Depression; Erythrocytes; Humans; Leukocytes; Schizophrenia; Serum Albumin; Tryptophan | 1979 |
The influence of oral tryptophan on cortical evoked responses in normals and schizophrenics.
Topics: Administration, Oral; Brain; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials; Humans; Male; Schizophrenia; Tryptophan; Vision, Ocular | 1979 |
Blood-brain movements of tryptophan and tyrosine in manic-depressive illness and schizophrenia.
Topics: Adult; Bipolar Disorder; Blood-Brain Barrier; Brain; Dihydroxyphenylalanine; Humans; Middle Aged; Schizophrenia; Serotonin; Tryptophan; Tyrosine | 1979 |
[Psychopharmacology of tryptophan (author's transl)].
Topics: Animals; Bipolar Disorder; Depression; Humans; Mental Disorders; Parkinson Disease; Schizophrenia; Serotonin; Sleep; Tryptophan | 1977 |
[Stimulating effect of schizophrenic patients' plasma on the cellular incorportation of tryptophan in vitro].
Topics: Adenylate Kinase; Adult; Animals; Chickens; Creatine Kinase; Erythrocytes; Female; Hemolysis; Humans; Immune Sera; L-Lactate Dehydrogenase; Male; Middle Aged; Schizophrenia; Tryptophan | 1979 |
Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
Topics: Adult; Affective Symptoms; Aged; Biogenic Amines; Bipolar Disorder; Depression; Electroencephalography; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lithium; Male; Middle Aged; Probenecid; Psychiatric Status Rating Scales; Schizophrenia; Tryptophan | 1977 |
[Uptake of tryptophan and tyrosine in some cases of manic depressive psychosis and schizophrenia (author's transl)].
Topics: Bipolar Disorder; Brain; Humans; Protein Binding; Schizophrenia; Tryptophan; Tyrosine | 1978 |
Classically conditioned autonomic discrimination and tryptophan uptake in chronic schizophrenia.
Topics: Adult; Autonomic Nervous System; Chronic Disease; Conditioning, Classical; Discrimination Learning; Humans; Male; Schizophrenia; Tryptophan | 1978 |
Schizophrenia, rheumatoid arthritis and trytophan metabolism.
Topics: Arthritis, Rheumatoid; Female; Humans; Male; Methionine; Methylation; Monoamine Oxidase; Protein Binding; Schizophrenia; Serotonin; Synovial Fluid; Tryptamines; Tryptophan | 1978 |
A study of relationships of serum glucose, insulin, free fatty acids, and free and total tryptophan to mental illness.
Topics: Adolescent; Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucose; Glucose Tolerance Test; Hallucinations; Humans; Insulin; Male; Mental Disorders; Middle Aged; Neurotic Disorders; Schizophrenia; Time Factors; Tryptophan | 1978 |
[Effect of schizophrenic patients' plasma on 14C-tryptophan incorporation in chicken erythrocytes].
Topics: Adult; Animals; Chickens; Erythrocytes; Female; Humans; Immune Sera; Male; Middle Aged; Schizophrenia; Tryptophan | 1978 |
Pellagra and mental disturbance.
Topics: Animals; Brain; Diet; Hartnup Disease; Humans; Mental Disorders; Nicotinic Acids; Pellagra; Pyridoxine; Rats; Schizophrenia; Tryptophan; Zea mays | 1978 |
[Schizophrenia and addiction].
Topics: Adult; Amphetamines; Cybernetics; Dopamine; Endorphins; Humans; Lysergic Acid Diethylamide; Male; Norepinephrine; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders; Tryptophan | 1978 |
Cerebral circulation and EEG alpha frequency in relation to daily fluctuations in psychotic behavior.
Topics: Adult; Alpha Rhythm; Bipolar Disorder; Circadian Rhythm; Female; Humans; Longitudinal Studies; Menstruation; Middle Aged; Periodicity; Phenelzine; Psychiatric Status Rating Scales; Psychotic Disorders; Remission, Spontaneous; Schizophrenia; Schizophrenia, Catatonic; Time Factors; Tryptophan | 1976 |
An electrophysiological study on the effects of tryptophan and cortisol on schizophrenic and other mentally ill patient groups and on normal subjects.
Topics: Adolescent; Adult; Age Factors; Animals; Brain; Carbon Dioxide; Electrophysiology; Female; Frontal Lobe; Humans; Hydrocortisone; Hydroxylation; Indoles; Male; Menopause; Mental Disorders; Middle Aged; Psychotropic Drugs; Schizophrenia; Sex Factors; Tryptophan | 1976 |
Insulin coma therapy: decrease of plasma tryptophan in man.
Topics: Adult; Convulsive Therapy; Fatty Acids, Nonesterified; Female; Glucose; Humans; Hypoglycemia; Insulin Coma; Male; Schizophrenia; Tryptophan; Tyrosine | 1976 |
Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients.
Topics: Adult; Aged; Anxiety Disorders; Brain Diseases; Cerebral Ventricles; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Middle Aged; Obsessive-Compulsive Disorder; Phenylacetates; Schizophrenia; Tryptophan; Tyrosine | 1976 |
Schizophrenia, a disorder of tryptophan metabolism.
Topics: Catecholamines; Diet; Hallucinogens; Humans; Indoles; Metabolism, Inborn Errors; Monoamine Oxidase; Schizophrenia; Tryptophan | 1975 |
Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
Topics: 5-Methoxytryptamine; Adult; Bufotenin; Chronic Disease; Epinephrine; Female; Humans; Hydroxyindoleacetic Acid; Methylation; Middle Aged; N,N-Dimethyltryptamine; Norepinephrine; Phenelzine; Schizophrenia; Serotonin; Tryptamines; Tryptophan | 1976 |
[Hypothetical concept: the physiopathological entity of monoaminergic psychoses].
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Behavior, Animal; Bipolar Disorder; Blood-Brain Barrier; Catecholamines; Diet; Humans; Levodopa; Neurons; Rats; Schizophrenia; Serotonin; Sexual Behavior; Tryptophan; Tyrosine | 1975 |
Changes in serum tryptophan and albumin binding of tryptophan in chlorpromazine-treated chronic schizophrenics on withdrawal and restoration of drug therapy.
Topics: Adult; Amino Acids; Brain; Chlorpromazine; Chronic Disease; Fatty Acids, Nonesterified; Humans; Male; Middle Aged; Placebos; Protein Binding; Schizophrenia; Serotonin; Serum Albumin; Tryptophan | 1975 |
A case of drug-drug interaction involving clozapine.
Topics: Adult; Ascorbic Acid; Clozapine; Drug Eruptions; Drug Interactions; Humans; Male; Niacin; Schizophrenia; Schizophrenic Psychology; Tryptophan | 1991 |
L-tryptophan in neuroleptic-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benztropine; Humans; Male; Middle Aged; Parasympatholytics; Pilot Projects; Psychomotor Agitation; Schizophrenia; Tryptophan | 1990 |
From the Food and Drug Administration.
Topics: Clozapine; Dibenzazepines; Humans; Methadone; Schizophrenia; Tryptophan; United States; United States Food and Drug Administration | 1990 |
Relationship between tryptophan and serotonin concentrations in postmortem human brain.
Topics: Brain; Humans; Hydroxyindoleacetic Acid; Indoles; Schizophrenia; Serotonin; Suicide; Tryptophan | 1987 |
Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals.
Topics: Adolescent; Adult; Bombesin; Cholecystokinin; Female; Humans; Hydrocortisone; Male; Middle Aged; Peptides; Pimozide; Probenecid; Schizophrenia; Somatostatin; Tryptophan | 1985 |
Rheumatoid arthritis and schizophrenia: are they mutually exclusive?
Topics: Anti-Inflammatory Agents; Antipsychotic Agents; Arthritis, Rheumatoid; Endorphins; Environment; Humans; Prostaglandins; Schizophrenia; Serotonin; Tryptophan | 1985 |
Endocrine responses to tryptophan infusion in schizophrenic patients treated with neuroleptics.
Topics: Adult; Antipsychotic Agents; Female; Growth Hormone; Humans; Male; Pituitary Gland, Anterior; Prolactin; Schizophrenia; Tryptophan | 1987 |
Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients.
Topics: Adult; Aged; Amino Acids; Amygdala; Brain Chemistry; Chronic Disease; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neurotransmitter Agents; Postmortem Changes; Schizophrenia; Tryptophan | 1987 |
Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.
Topics: Adult; Cyproheptadine; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Prolactin; Reference Values; Schizophrenia; Serotonin; Sleep Stages; Synaptic Transmission; Tryptophan | 1985 |
[Alpha-rhythm asymmetry of schizophrenic patients before and after tryptophan administration].
Topics: Acute Disease; Adult; Alpha Rhythm; Dominance, Cerebral; Female; Hallucinations; Humans; Male; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Tryptophan | 1987 |
[Tryptophan-loading in schizophrenia and endogenous depression].
Topics: Administration, Oral; Adult; Depressive Disorder; Female; Humans; Kinetics; Male; Schizophrenia; Tryptophan | 1987 |
Schizophrenia--new concepts.
Topics: Alpha-Globulins; Brain; Chronic Disease; Humans; Lipoproteins; Schizophrenia; Synaptic Transmission; Tryptophan | 1971 |
Conformation of a unique plasma protein in schizophrenia.
Topics: 5-Hydroxytryptophan; Adult; Alpha-Globulins; Amino Acids; Animals; Brain; Brain Chemistry; Chemical Phenomena; Chemistry; Chickens; Chromatography, DEAE-Cellulose; Electrophoresis, Disc; Humans; Male; Nerve Tissue Proteins; Optical Rotatory Dispersion; Schizophrenia; Tryptophan | 1971 |
The effect of the plasma factor on the uptake of amino acids by neural tissue.
Topics: Adolescent; Adult; Alpha-Globulins; Animals; Brain; Brain Chemistry; Calcium; Histocytochemistry; Humans; In Vitro Techniques; Male; Neurons; Oxygen; Potassium; Rats; Schizophrenia; Sodium; Time Factors; Tryptophan | 1972 |
Conformational variation in a human plasma lipoprotein.
Topics: Adult; Alpha-Globulins; Amino Acids; Animals; Biological Transport; Centrifugation, Density Gradient; Cholesterol; Chromatography; Circular Dichroism; Electrophoresis; Electrophoresis, Disc; Humans; Lipids; Lipoproteins; Male; Middle Aged; Molecular Weight; Oleic Acids; Optical Rotatory Dispersion; Protein Conformation; Rats; Schizophrenia; Stearic Acids; Tryptophan | 1972 |
Electrophysiological phenomena associated with the S-protein system in normal and schizophrenic subjects.
Topics: 5-Hydroxytryptophan; Adult; Alpha-Globulins; Animals; Chickens; Electrophysiology; Erythrocytes; Female; Frontal Lobe; Glutamates; Humans; In Vitro Techniques; Male; Middle Aged; Proline; Protein Conformation; Pyrrolidonecarboxylic Acid; Rats; Schizophrenia; Serotonin; Tryptophan | 1973 |
Distribution and mechanism of action of the anti-S protein in human brain.
Topics: Adult; Alpha-Globulins; Animals; Brain; Brain Chemistry; Chickens; Erythrocytes; Humans; In Vitro Techniques; Middle Aged; Nerve Tissue Proteins; Schizophrenia; Tissue Extracts; Tryptophan | 1973 |
The effects of the S-protein on intracranial self-stimulation in the rat.
Topics: Alpha-Globulins; Animals; Behavior, Animal; Cattle; Conditioning, Operant; Electric Stimulation; Humans; Hypothalamus; Male; Molecular Weight; N,N-Dimethyltryptamine; Protein Conformation; Rats; Reinforcement Schedule; Reward; Schizophrenia; Self Stimulation; Tryptophan | 1974 |
A theory of neuronal malfunction in schizophrenia.
Topics: Alpha-Globulins; Amino Acids; Animals; Antigens; Autoantibodies; Beta-Globulins; Cell Membrane Permeability; Chickens; Erythrocytes; Glutamates; Hemolysin Proteins; Humans; In Vitro Techniques; Neurons; Phenylalanine; Rats; Schizophrenia; Synapses; Synaptic Transmission; Tryptophan | 1969 |
Amino acid transport and the plasma factor in schizophrenia.
Topics: 5-Hydroxytryptophan; Alpha-Globulins; Amino Acids; Animals; Biological Transport; Carbon Isotopes; Chickens; Erythrocytes; Glutamates; Humans; Ouabain; Schizophrenia; Tryptophan | 1969 |
Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
Topics: Adult; Catatonia; Creatine; Cysteine; Humans; Indoleacetic Acids; Male; Middle Aged; Niacinamide; Paranoid Disorders; Schizophrenia; Tranylcypromine; Tryptamines; Tryptophan | 1967 |
[Tryptophan-nicotinic acid metabolism in psychiatric diseases].
Topics: Adult; Child; Child, Preschool; Chromatography; Down Syndrome; Female; Humans; Intellectual Disability; Male; Nicotinic Acids; Schizophrenia; Sex Factors; Tryptophan | 1968 |
Serum levels of phenylalanine and tyrosine in Huntington's chorea.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Body Weight; Dopamine; Female; Humans; Huntington Disease; Male; Middle Aged; Norepinephrine; Parasympatholytics; Phenylalanine; Psychotic Disorders; Reserpine; Schizophrenia; Tryptophan; Tyrosine | 1971 |
Serum from schizophrenic patients. Effect on cellular lactate stimulation and tryptophan uptake.
Topics: Animals; Blood; Chickens; Chromatography, Affinity; Complement System Proteins; Edetic Acid; Erythrocytes; Guinea Pigs; Hemolysis; Humans; Immunoglobulin M; Lactates; Lipoproteins; Lipoproteins, LDL; Male; Rabbits; Schizophrenia; Tryptophan | 1973 |
[Effect of tryptophan on the somatotropic hormone during sleep in schizophrenics].
Topics: Adult; Chronic Disease; Circadian Rhythm; Growth Hormone; Humans; Middle Aged; Pituitary Gland; Schizophrenia; Sleep; Sleep Stages; Sleep, REM; Tryptophan | 1973 |
Serum tryptophan binding in chlorpromazine-treated chronic schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Diffusion; Fatty Acids, Nonesterified; Humans; Liver; Male; Orphenadrine; Protein Binding; Schizophrenia; Serum Albumin; Time Factors; Tryptophan; Tryptophan Oxygenase | 1974 |
The effect of insulin load on plasma tryptophan levels in schizophrenic patients.
Topics: Depression, Chemical; Humans; Insulin; Schizophrenia; Tryptophan | 1974 |
Cerebral hemodynamic effects of chronic tryptophan feeding in man as measured by quantified cerebral impedance plethysmography.
Topics: Administration, Oral; Adult; Blood Circulation Time; Blood Pressure; Carotid Arteries; Cerebrovascular Circulation; Female; Heart Rate; Humans; Middle Aged; Phenelzine; Plethysmography, Impedance; Regional Blood Flow; Schizophrenia; Tryptophan; Vascular Resistance; Vertebral Artery | 1974 |
Fluorometric measurement of 5-hydroxyindoleacetic acid (5HIAA) and tryptophan in human CSF: effects of high doses of probenecid.
Topics: Administration, Oral; Adolescent; Adult; Bipolar Disorder; Brain Chemistry; Depression; Female; Fluorometry; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Probenecid; Schizophrenia; Tryptophan | 1974 |
Plasma tryptophan tolerance curves in drug free normal controls, schizophrenic patients and prisoner volunteers.
Topics: Acute Disease; Administration, Oral; Adult; Chlorpromazine; Chronic Disease; Circadian Rhythm; Depression; Fasting; Food; Half-Life; Humans; Male; Middle Aged; Personality Disorders; Prisoners; Schizophrenia; Tryptophan | 1974 |
Abnormalities in tryptophan metabolites in schizophrenia.
Topics: Animals; Cattle; Electrodes, Implanted; Humans; Proteins; Rats; Schizophrenia; Tryptophan | 1974 |
Experimental data to the pathogenesis of cryptopyrrole excretion in schizophrenia, I.
Topics: Chromatography; Depression; Epilepsy; Humans; Mass Screening; Paranoid Disorders; Periodicity; Porphyrins; Psychotic Disorders; Pyrroles; Schizophrenia; Tryptophan | 1972 |
Low plasma tryptophan levels in recently hospitalized schizophrenics.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Bipolar Disorder; Chronic Disease; Depression; Diet; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Phenylalanine; Racial Groups; Schizophrenia; Sex Factors; Tryptophan; Tyrosine | 1973 |
Association of plasma tryptophan levels with clinical change in female schizophrenic patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Phenylalanine; Racial Groups; Remission, Spontaneous; Schizophrenia; Sex Factors; Tryptophan; Tyrosine | 1973 |
[Biochemical study of a schizophreniac].
Topics: Adult; Cysteine; Humans; Male; Methylation; Monoamine Oxidase Inhibitors; Phenylalanine; Schizophrenia; Transferases; Tryptophan | 1973 |
Relationship of dietary tryptophan and niacin to tryptophan metabolism in schizophrenics and nonschizophrenics.
Topics: Acetates; Aminohippuric Acids; Diet; Female; Humans; Hydroxyindoleacetic Acid; Indican; Indoles; Kynurenic Acid; Kynurenine; Male; Nicotinic Acids; ortho-Aminobenzoates; Schizophrenia; Tryptophan; Tryptophan Hydroxylase; Tryptophan Oxygenase; Vitamin B 6 Deficiency; Xanthurenates | 1974 |
Amines and aphrodisiacs in chronic schizophrenia.
Topics: Adult; Aphrodisiacs; Epinephrine; Evaluation Studies as Topic; Female; Humans; Hydroxyindoleacetic Acid; Middle Aged; Phenelzine; Psychiatric Status Rating Scales; Schizophrenia; Sexual Behavior; Tranquilizing Agents; Tryptamines; Tryptophan | 1972 |
Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
Topics: 5-Hydroxytryptophan; Adult; Chromatography, Gas; Chromatography, Paper; Chromatography, Thin Layer; Cysteine; Hallucinogens; Humans; Male; Methionine; Middle Aged; Schizophrenia; Serotonin; Tranylcypromine; Tryptamines; Tryptophan | 1970 |
Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
Topics: Adult; Creatinine; Drug Synergism; Humans; Indoleacetic Acids; Male; Methionine; Middle Aged; Schizophrenia; Schizophrenic Psychology; Tranylcypromine; Tryptamines; Tryptophan | 1969 |
Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
Topics: Adult; Amines; Behavior; Chromatography, Gas; Chromatography, Ion Exchange; Chromatography, Thin Layer; Creatinine; Cysteine; Diet; Hallucinogens; Humans; Indoleacetic Acids; Male; Methionine; Middle Aged; Schizophrenia; Spectrum Analysis; Tranylcypromine; Tryptamines; Tryptophan | 1970 |
Electrophysiological studies on the brain. Effects of nucleotide and tryptophan metabolites as modified by polyamines in normal and psychotic subjects.
Topics: Amines; Anxiety; Brain; Capillary Permeability; Electrophysiology; Feedback; Humans; Neurotic Disorders; Nucleoproteins; Nucleotides; Psychotic Disorders; Schizophrenia; Tranquilizing Agents; Tryptophan | 1970 |
Cerebrospinal fluid 5-hydroxyindoles and behavior after L-tryptophan and pyridoxine adminstration to psychiatric patients.
Topics: Adolescent; Adult; Behavior; Depression; Female; Humans; Indoles; Male; Middle Aged; Psychological Tests; Pyridoxine; Schizophrenia; Tryptophan | 1970 |
[The effect of phenamine on medicinal parkinsonism and retardation of movement upon stimulation of the caudate nucleus (a clinico-experimental study)].
Topics: Amphetamine; Caudate Nucleus; Female; Haloperidol; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Schizophrenia; Tryptophan | 1970 |
[Blood serum tryptophan in schizophrenic patients and the dependence of its level on treatment with neuroleptics].
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Schizophrenia; Tranquilizing Agents; Tryptophan | 1970 |
[Basic research in schizophrenia].
Topics: Adrenal Glands; Amphetamine; Chemical Phenomena; Chemistry; Dopamine; Female; Hirsutism; Humans; Monoamine Oxidase Inhibitors; Phenethylamines; Schizophrenia; Thyroid Gland; Tryptamines; Tryptophan | 1971 |
Excretion of indoleamines in schizophrenia.
Topics: Amines; Humans; Indoles; Methionine; Monoamine Oxidase Inhibitors; Schizophrenia; Tryptamines; Tryptophan | 1967 |
Screening for aminoacidurias in psychiatric inpatients.
Topics: Affective Symptoms; Amino Acid Metabolism, Inborn Errors; Brain Damage, Chronic; Depression; Drug Synergism; Hartnup Disease; Homocystinuria; Hospitals, Psychiatric; Humans; Intellectual Disability; Mass Screening; Massachusetts; Mental Disorders; Methionine; Monoamine Oxidase Inhibitors; Neurotic Disorders; Personality Disorders; Phenylketonurias; Schizophrenia; Substance-Related Disorders; Tryptophan | 1969 |
Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Catecholamines; Humans; Male; Methionine; Middle Aged; Norepinephrine; Psychopharmacology; Schizophrenia; Tranylcypromine; Tryptamines; Tryptophan; Urine | 1965 |
Antipyridoxine effect of D-penicillamine in schizophrenic men.
Topics: Adult; Ceruloplasmin; Copper; Fluorometry; Humans; Male; Middle Aged; Penicillamine; Pyridoxine; Schizophrenia; Tryptophan; Xanthurenates | 1966 |